Skip to main content
Erschienen in: Annals of Nuclear Medicine 10/2011

01.12.2011 | Original article

Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy

verfasst von: Yukiko Yano, Kiminori Sugino, Junko Akaishi, Takashi Uruno, Keiko Okuwa, Hiroshi Shibuya, Wataru Kitagawa, Mitsuji Nagahama, Kunihiko Ito, Koichi Ito

Erschienen in: Annals of Nuclear Medicine | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

The purpose of this study was to clarify the efficacy of radioiodine (RI) therapy in Japanese patients with autonomously functioning thyroid nodules (AFTNs).

Methods

We performed a retrospective analysis to assess the management of AFTN patients. Thyroid lobectomy was performed to treat toxic adenoma (TA) patients, and total thyroidectomy to treat toxic multinodular goiter (TMNG) patients. RI therapy was administered in the form of a single dose (500 MBq) of isotope in the outpatient clinic. Percutaneous ethanol injection therapy (PEIT) was performed under ultrasound guidance.

Results

Of the total 205 patients, consisting of 159 TA and 46 TMNG patients, 99 underwent surgery, 50 received RI therapy, and 56 received PEIT. Remission of thyrotoxicosis was achieved in all of the patients who were treated surgically. Hypothyroidism was documented in six of the 72 patients who were treated surgically other than by total thyroidectomy. Remission of thyrotoxicosis was observed in 43 of the 50 patients who were treated by RI therapy. Nine TA patients developed hypothyroidism during the follow-up period after RI therapy. Several PEIT sessions were required to achieve a remission of thyrotoxicosis. Remission of thyrotoxicosis was achieved in 29 of the 56 patients treated by PEIT, and thyrotoxicosis recurred in 17 these 56 patients.

Conclusion

Surgery is the treatment of choice for large nodules and nodules that are resistant to other treatments, because it allows prompt control of thyrotoxicosis. RI therapy is a safe and effective means of controlling thyrotoxicosis in AFTN patients. We conclude that RI therapy is the treatment of choice for definitive treatment of AFTN patients who do not have local compression symptoms.
Literatur
1.
Zurück zum Zitat Blum M, Shenkman L, Hollander CS. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am J Med Sci. 1975;269:43–50.PubMedCrossRef Blum M, Shenkman L, Hollander CS. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am J Med Sci. 1975;269:43–50.PubMedCrossRef
2.
Zurück zum Zitat Wiener JD. Long-term follow-up in untreated Plummer’s disease (autonomous goiter). Clin Nucl Med. 1987;12:198–203.PubMedCrossRef Wiener JD. Long-term follow-up in untreated Plummer’s disease (autonomous goiter). Clin Nucl Med. 1987;12:198–203.PubMedCrossRef
3.
Zurück zum Zitat Livraghi T, Paracchi A, Ferrari C, Bergonzi M, Garavaglia G, Raineri P, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Radiology. 1990;175:827–9.PubMed Livraghi T, Paracchi A, Ferrari C, Bergonzi M, Garavaglia G, Raineri P, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Radiology. 1990;175:827–9.PubMed
4.
Zurück zum Zitat Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino AT. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology. 1994;190:529–33.PubMed Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino AT. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology. 1994;190:529–33.PubMed
5.
Zurück zum Zitat Tajiri J. Radioiodine treatment of patients with autonomously functioning thyroid nodules at outpatient clinic. Kaku Igaku. 2006;43:75–83.PubMed Tajiri J. Radioiodine treatment of patients with autonomously functioning thyroid nodules at outpatient clinic. Kaku Igaku. 2006;43:75–83.PubMed
6.
Zurück zum Zitat Fukunari N. PEI therapy for thyroid lesions. Biomed Pharmacother. 2002;56(Suppl 1):79s–82s.PubMed Fukunari N. PEI therapy for thyroid lesions. Biomed Pharmacother. 2002;56(Suppl 1):79s–82s.PubMed
7.
Zurück zum Zitat Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am. 1995;24:663–710.PubMed Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am. 1995;24:663–710.PubMed
8.
Zurück zum Zitat Hamburger JI. The autonomously functioning thyroid nodule: Goetsch’s disease. Endocr Rev. 1987;8:439–47.PubMedCrossRef Hamburger JI. The autonomously functioning thyroid nodule: Goetsch’s disease. Endocr Rev. 1987;8:439–47.PubMedCrossRef
9.
Zurück zum Zitat Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993;365:649–51.PubMedCrossRef Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993;365:649–51.PubMedCrossRef
10.
Zurück zum Zitat Ferrari C, Reschini E, Paracchi A. Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol. 1996;135:383–90.PubMedCrossRef Ferrari C, Reschini E, Paracchi A. Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol. 1996;135:383–90.PubMedCrossRef
11.
Zurück zum Zitat Holm LE, Lundell G, Israelsson A, Dahlqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med. 1982;23:103–7.PubMed Holm LE, Lundell G, Israelsson A, Dahlqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J Nucl Med. 1982;23:103–7.PubMed
12.
Zurück zum Zitat Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf). 2005;62:331–5.CrossRef Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf). 2005;62:331–5.CrossRef
13.
Zurück zum Zitat Mariotti S, Martino E, Francesconi M, Ceccarelli C, Grasso L, Lippi F, et al. Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid ‘hot’ nodule. Acta Endocrinol (Copenh). 1986;113:500–7. Mariotti S, Martino E, Francesconi M, Ceccarelli C, Grasso L, Lippi F, et al. Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid ‘hot’ nodule. Acta Endocrinol (Copenh). 1986;113:500–7.
14.
Zurück zum Zitat Goletti O, Monzani F, Caraccio N, Del Guerra P, Lippolis PV, Pucciarelli M, et al. Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: optimization of treatment and short term outcome. World J Surg. 1992;16:784–9.PubMedCrossRef Goletti O, Monzani F, Caraccio N, Del Guerra P, Lippolis PV, Pucciarelli M, et al. Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: optimization of treatment and short term outcome. World J Surg. 1992;16:784–9.PubMedCrossRef
15.
Zurück zum Zitat Martino E, Murtas ML, Loviselli A, Piga M, Petrini L, Miccoli P, et al. Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery. 1992;112:1161–4.PubMed Martino E, Murtas ML, Loviselli A, Piga M, Petrini L, Miccoli P, et al. Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery. 1992;112:1161–4.PubMed
Metadaten
Titel
Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy
verfasst von
Yukiko Yano
Kiminori Sugino
Junko Akaishi
Takashi Uruno
Keiko Okuwa
Hiroshi Shibuya
Wataru Kitagawa
Mitsuji Nagahama
Kunihiko Ito
Koichi Ito
Publikationsdatum
01.12.2011
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 10/2011
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-011-0526-7

Weitere Artikel der Ausgabe 10/2011

Annals of Nuclear Medicine 10/2011 Zur Ausgabe